Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 9Lymphoma, Non-Hodgkin 7Hodgkin Disease 5Lymphoma, Mantle-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Recurrence 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Myeloid, Acute 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Hematologic Neoplasms 2Hematologic Diseases 2Breast Neoplasms, Male 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Sezary Syndrome 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1

Interventions

Doxorubicin 18Vincristine 15Zidovudine 11Bleomycin 11Cyclophosphamide 9Etoposide 8Interferon alpha-2 6Prednisone 5Cytarabine 5tecogalan 4sargramostim 4Rituximab 4Polymerase Chain Reaction 4Liposomes 4Filgrastim 4Dexamethasone 4Methotrexate 3Leucovorin 3Fluorouracil 3interferon alfa-n1 2Watchful Waiting 2Vinblastine 2Tumor Necrosis Factor-alpha 2Thalidomide 2Semaxinib 2Ritonavir 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Light Coagulation 2Isotretinoin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × HIV Infections × Leukapheresis × Clear all
NCT00968630 2017-05-24

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
9 enrolled
Other hematologic neoplasm

HIV Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡